☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Authorizes
Roche's Enspryng (satralizumab) Receives Health Canada Approval for Neuromyelitis Optica Spectrum Disorder
September 1, 2020
The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19
March 31, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
